Randomized Controlled Trial
Different effects of low-dose transdermal and oral oestrogen therapy on procarboxy-peptidase U, an inhibitor of fibrinolysis, in healthy postmenopausal women: a randomised, placebo-controlled study
- PMID: 15735823
Item in Clipboard
Randomized Controlled Trial
Different effects of low-dose transdermal and oral oestrogen therapy on procarboxy-peptidase U, an inhibitor of fibrinolysis, in healthy postmenopausal women: a randomised, placebo-controlled study
Thromb Haemost.
2005 Mar.
No abstract available
Similar articles
-
Effects of oral and transdermal estrogen replacement therapy on markers of coagulation, fibrinolysis, inflammation and serum lipids and lipoproteins in postmenopausal women.Thromb Haemost. 2001 Apr;85(4):619-25. Thromb Haemost. 2001. PMID: 11341495 Clinical Trial.
-
Oral oestradiol/trimegestone replacement reduces procarboxypeptidase U (TAFI): a randomized, placebo- controlled, 12-week study in early postmenopausal women.J Intern Med. 2002 Mar;251(3):245-51. doi: 10.1046/j.1365-2796.2002.00960.x. J Intern Med. 2002. PMID: 11886484 Clinical Trial.
-
The effect of various menopausal hormone therapies on markers of inflammation, coagulation, fibrinolysis, lipids, and lipoproteins in healthy postmenopausal women.Menopause. 2006 Jul-Aug;13(4):643-50. doi: 10.1097/01.gme.0000198485.70703.7a. Menopause. 2006. PMID: 16837886 Clinical Trial.
-
[Hormone replacement therapy - less is often more].Zentralbl Gynakol. 2001 Sep;123(9):546-7. doi: 10.1055/s-2001-18230. Zentralbl Gynakol. 2001. PMID: 11709750 Review. German.
-
Neuroendocrinology: Oestrogen therapy affects brain structure but not function.Nat Rev Neurol. 2016 Sep 28;12(10):561-2. doi: 10.1038/nrneurol.2016.147. Nat Rev Neurol. 2016. PMID: 27677967 Free PMC article. Review.
Cited by
-
Emerging selective estrogen receptor modulators: special focus on effects on coronary heart disease in postmenopausal women.Drugs. 2006;66(2):191-221. doi: 10.2165/00003495-200666020-00005. Drugs. 2006. PMID: 16451093 Review.